Skip to Content


You are viewing the 1st of the 2 courses UPMC Physician Resources permits you to view without registering. To have full access to our FREE courses on our website, please register or log in now.

Drs. Jessica Bon Field and Frank Sciurba join together to present on COPD. Dr. Bon Field discusses studies that have been published in the past 12-15 months that have looked at early COPD as well as the comprehensive management of COPD patients. Dr. Sciurba discusses Inhaled Corticosteroids in COPD  and the concept of  Asthma and COPD overlap.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Recognize that lung function attained early in adulthood may impact the development of COPD later in life and that a wide range of lung function trajectories exist.
  • Appreciate that current and former smokers with symptoms but preserved pulmonary function have respiratory exacerbations, shorter walk distance, and evidence of subtle airway disease.
  • Describe the impact of a health coaching intervention on COPD readmission rates and outcomes.
  • Describe how recent literature supports a clinical precision approach to selecting patients for bronchoscopic volume reduction.
  • Recognize that only a subset of COPD patients benefit from inhaled corticosteroids and to begin to select appropriate patients for treatment.

Reading Resources:

  1. Watz et. al. The Lancet Respiratory Medicine 2016; 5:390–398.
  2. Postma and Rabe. NEJM 2015; 373:1241-1249.
  3. Wedzicha et. al. NEJM 2016; 374:2222-2234.
  4. Klooster et. al. NEJM 2016; 373: 2325-2335.
  5. Sciurba et. al. JAMA 2016; 315:2178 - 2189.


Dr. Bon Field has financial interests with the following any entity or entities producing health care goods or services as indicated below:

  • Grant/Research: Astra Zeneca

Dr. Sciurba has financial interests with the following any entity or entities producing health care goods or services as indicated below:

  • Grant/Research Support: Boehringer-Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline, PneumRX, Inc., PulmonX
  • Consultant: Boehringer-Ingelheim Pharmaceuticals, Inc., GlaxoSmithKline

All presenters disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above.  No other planners, members of the planning committee, speakers, presenters, authors, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

Accreditation Statement:

The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Pittsburgh School of Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Each physician should only claim credit commensurate with the extent of their participation in the activity. Other health care professionals are awarded (0.1) continuing education units (CEU) which are equivalent to 1 contact hour.

For your credit transcript, please access our website 4 weeks post-completion at and follow the link to the Credit Transcript page. If you do not provide the last 5 digits of your SSN on the next page you will not be able to access a CME credit transcript. Providing your SSN is voluntary.

Release Date: 4/11/17 | Last Modified On: 4/11/17 | Expires: 4/13/20

This course has been expired.